Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2005

Open Access 01.12.2005 | Research

Resection of small plexiform neurofibromas in neurofibromatosis type 1 children

verfasst von: Reinhard E Friedrich, Rainer Schmelzle, Melanie Hartmann, Carsten Fünsterer, Victor-F Mautner

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2005

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Plexiform neurofibromas (PNF) are benign tumors of the peripheral nerve which mostly develop in patients with neurofibromatosis type 1 (NF1). Surgical interventions are usually not applied to children with small tumors. These are rather restricted to debulking of larger tumors in adults that cause clinical complications or aesthetic disfigurement. In most cases, a total resection of PNF is not possible due to the network-like growth of the tumors.

Patients and methods

Early surgical intervention was carried out for 9 small PNFs in 7 NF1 children. Tumor resection was performed following the graphical delineation of the affected skin and according the MRI findings.

Results

Total resection was achieved for all 9 PNF without causing any neurological or organic deficit. Annual magnetic resonance tomography over a period of four years did not reveal any relapse of the tumors.

Conclusions

Early surgical intervention for small superficial PNFs in NF1 children have various advantages and may especially be considered a strategy to prevent progression.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-3-6) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

REF and RS carried out the surgical intervention for the tumors and post-operational care of the patients.
CF carried out the MRI and was involved in the diagnosis of PNF.
MH and VFM did the diagnosis and were responsible for management and consulting of the patients.
REF and VFM designed the study and prepared the manuscript.
All authors read and approved the final version of the manuscript.

Background

Plexiform neurofibromas (PNF) are benign tumors originating from nerve sheath cells, subcutaneous, or visceral peripheral nerves and can involve multiple fascicles [1]. PNF occur almost exclusively in patients with NF1, an autosomal dominant disorder caused by defect of one allele of the tumor suppressor gene, NF1 on 17q [25]. At least 30% of NF1 patients suffer from PNF [2, 6, 7], which are often present at birth and progress during the first years of life. The growth rate and pattern of PNF vary to a large extent and their growth spurts are unpredictable. PNF can arise in various parts of the body, for example as anterior mediastinal masses, sciatic nerve lesions with pelvic extension, or perirectal plexiform and uterine tumors, often leading to severe clinical complications [7]. Especially tumors occurring in the head and neck area often lead to facial disfigurement and functional deficits. Due to large size of the tumors and involvement of multiple fascicles of nerves and tissues, the risk of neurological and functional destruction upon tumor resection is high. Surgical interventions are thus commonly postponed as long as possible. In addition, most surgical interventions are limited to debulking and rests of tumors often re-grow afterwards leading to the requirement of repeated intervention [810].
Previously we reported that PNF can be distinguished into three growth categories using magnetic resonance imaging (MRI): superficial, displacing and invasive. Superficial PNF arise from subcutaneous or cutaneous nerves and may remain within the upper layer of the skin – usually not involving major nerves [10]. Subtotal and total resection without functional destruction is often possible for superficial PNF, as demonstrated in our recent study [11]. In contrast, invasive PNF infiltrate multiple tissue planes and are thus much more difficult or impossible to resect. Superficial PNF show progressive growth and it is unknown whether or not a superficial PNF may change to displacing or invasive types. Early resection of small superficial PNF may thus be considered as an advantageous treatment option.
In this study, we present the results of early intervention for 9 PNFs in 7 NF1 children aged 3 to 15 years.

Patients and methods

The 7 children were examined in our NF-Clinic in the Department of Maxillofacial Surgery, University Hospital Eppendorf, Hamburg. Diagnosis of NF1 was based on the NIH criteria [6]. Informed consent was obtained from parents of these children. All patients received dermatological, neurological and ophthalmological examinations as well as an ultrasound of abdominal organs. PNF were diagnosed based on the following indications: subcutaneous location on palpation, associated with thickening of the skin, local hypertrophy, hair excess and hyperpigmentation on inspection, and prepubertal occurrence from the medical report. Magnetic resonance image (MRI) was done for the tumor regions at 1.5 Tesla with T1- and T2- weighted sequences including a short-tau inversion-recovery (STIR) sequence. Ultra rapid half Fourier single-shot turbo spin-echo (HASTE) sequences were used for imaging the trunk. Intravenous contrast medium was given to all patients. Tumor resection was performed following the graphical delineation of the affected skin and according the MRI findings. Tumor resection included the epidermal and subcutaneous layer with safety margins of 1 cm in all directions. Exploration of the underlying muscles was mandatory.

Results

Seven NF1 children, five boys and two girls, aged 3 to 15 years were included in this study. All of them met the NIH diagnostic criteria for NF1 [6]. PNF was initially diagnosed clinically and further ascertained by MRI (Figs. 1, 2, 3, 4, 5, 6, 7). Five tumors were histologically confirmed as PNF (Fig. 8). Other four were reported as diffuse neurofibromas due to lack of nerve fascicle in the examined sections. However, these tumors were parts of PNF. Five PNF in four children exhibited hyperpigmentation while the other two had hair excess in the tumor area. Two children had two and the other five had one PNF each. Size of tumors varied from 2 cm to 8 cm in greatest diameter (table 1). All PNF were superficial based on MRI. The tumor location was variable (table 1). Neither functional deficit nor pain was caused by the tumors at the time of surgery. Neither was there significant aesthetic disfigurement caused by the tumors.
Table 1
Clinical information
Patient number
Sex
Age at surgery
Tumor location
Hyper pigmentation
hair growth
Size (greatest diameter)
Histology
post-operative MRI
Annual MRI follow up
1
f
5
upper arm right
no
no
4 cm
PNF
yes
yes
  
5
thorax right
yes
no
4 cm
PNF
yes
yes
2
m
15
Adams apple
no
no
5 cm
PNF
no
yes
3
f
14
rib bow left
no
no
4 cm
PNF
no
yes
  
14
paraumbilical left
no
no
3 cm
PNF
no
yes
4
m
3
thigh left
yes
yes
7 cm
PNF
no
yes
5
m
4
thorax left
yes
no
2 cm
PNF
yes
yes
6
m
7
back right
yes
yes
8 cm
PNF
yes
yes
7
m
11
lower arm left
yes
no
5 cm
PNF
no
only 2003
In 2001, all seven children underwent surgical intervention for their nine PNF. During the mobilization of the underlying skin layers, three patients showed enlarged nerves running from subcutis to superficial muscle layers, which were identified and additionally resected. These enlarged nerves were proven to be PNF in all cases. Primary wound closure was achieved following the mobilization of the marginal skin. Healing followed without complications in all cases. The scars are relatively small and no hypertrophy was observed. The intervention was well tolerated by all children and recovery occurred within a few days.
Postoperative MRI was done for three children. Six children underwent follow-up examinations annually by MRI for three years. One child was only examined in 2003, two years after the operation. MRI revealed successful total resection for all 9 tumors (Figs. 1, 2, 3, 4, 5, 6, 7). So far, no tumor re-growth has been detected in any of the children.

Discussion

In this study we demonstrated that small superficial PNF can be completely resected, leaving scars without hypertrophy. Operation is relatively uncomplicated, allows healing by primary intention, requires only a few days of hospitalization and is thus no burden for even the youngsters. Within the clinical and radiological follow-up period of three years there was no re-growth of the tumors. However, it cannot be excluded that all tumor cells have been resected. Therefore those patients warrant further annual clinical examination.
The scars in some children may seem more obvious and disfiguring after the operation. However, in comparison to the complications the tumors may cause later, they are only of minor concern. Furthermore, these scars may be corrected later surgically.
Without resection, these small PNF are likely to grow continuously to a large or even very large size which often causes aesthetic disfigurement, functional deficits and pain. Resection of large tumors is much more difficult and total resection is usually not possible any more. Currently it is not clarified whether or not growth patterns of PNF might possibly change from superficial to displacing or to invasive types over time. Early surgical intervention of small superficial PNF may thus be considered as a preventive strategy for later disfigurement and functional deficits.
Adequate diagnosis of NF1 and thus small PNF in the pediatric age group is challenging. Children usually do not complain about subtle pain or discomfort in the affected skin region. Even in the presence of some symptoms parents are often not aware of the origin of the tumor. Only small PNF of the face and neck causing disfigurement in children tend to be recognized early. On the other hand, small PNF of the trunk and extremities which present with subtle hyperpigmentation, hair excess and palpable tumor tissue are frequently not noticed by the physicians. These tumors are rarely diagnosed correctly as PNF. In our cohort only one child received the diagnosis of a PNF correctly by the referring family physician. For better management and adequate treatment, efforts should be made to diagnose NF1 and PNF in their early stage.

Conclusions

Early surgical intervention of small superficial PNFs is uncomplicated, without burden for even the youngsters and enables total resection of the tumors. It may be considered as a preventive strategy for later disfigurement and functional deficits.

Acknowledgements

We thank Dr. L. Kluwe for helping preparing this manuscript. Written informed consent was obtained from parents of all the patients.
This study was supported by the Deutsche Krebshilfe project number: 70-3072-Ma4.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

REF and RS carried out the surgical intervention for the tumors and post-operational care of the patients.
CF carried out the MRI and was involved in the diagnosis of PNF.
MH and VFM did the diagnosis and were responsible for management and consulting of the patients.
REF and VFM designed the study and prepared the manuscript.
All authors read and approved the final version of the manuscript.
Literatur
1.
Zurück zum Zitat Kleinhues P, Cavenee WK: Tumours of the nervous system. World Health Classification of Tumours. 2000, IARC Press Lyon Kleinhues P, Cavenee WK: Tumours of the nervous system. World Health Classification of Tumours. 2000, IARC Press Lyon
2.
Zurück zum Zitat Huson SM, Hughes RAC: The Neurofibromatosis: A Pathogenetic and Clinical Overview. 1994, Chapman and Hall Medical, London Huson SM, Hughes RAC: The Neurofibromatosis: A Pathogenetic and Clinical Overview. 1994, Chapman and Hall Medical, London
3.
Zurück zum Zitat Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O'Connell P: A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell. 1990, 62: 193-201. 10.1016/0092-8674(90)90253-B. Erratum in: Cell 1990, 62: following 608.CrossRefPubMed Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O'Connell P: A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell. 1990, 62: 193-201. 10.1016/0092-8674(90)90253-B. Erratum in: Cell 1990, 62: following 608.CrossRefPubMed
4.
Zurück zum Zitat Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA: Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990, 62: 187-192. 10.1016/0092-8674(90)90252-A.CrossRefPubMed Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA: Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990, 62: 187-192. 10.1016/0092-8674(90)90252-A.CrossRefPubMed
5.
Zurück zum Zitat Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL: Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 1990, 249: 181-186. Erratum in: Science 1990, 250:1749.CrossRefPubMed Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL: Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 1990, 249: 181-186. Erratum in: Science 1990, 250:1749.CrossRefPubMed
6.
Zurück zum Zitat Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997, 278: 51-57. 10.1001/jama.278.1.51.CrossRefPubMed Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997, 278: 51-57. 10.1001/jama.278.1.51.CrossRefPubMed
7.
Zurück zum Zitat Tonsgard JH, Kwak SM, Short MP, Dachman AH: CT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions. Neurology. 1998, 50: 1755-60.CrossRefPubMed Tonsgard JH, Kwak SM, Short MP, Dachman AH: CT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions. Neurology. 1998, 50: 1755-60.CrossRefPubMed
8.
Zurück zum Zitat Needle MN, Cnaan A, Dattilo J, Chatten J, Phillips PC, Shochat S, Sutton LN, Vaughan SN, Zackai EH, Zhao H, Molloy PT: Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974–1994. J Pediatr. 1997, 131: 678-682.CrossRefPubMed Needle MN, Cnaan A, Dattilo J, Chatten J, Phillips PC, Shochat S, Sutton LN, Vaughan SN, Zackai EH, Zhao H, Molloy PT: Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974–1994. J Pediatr. 1997, 131: 678-682.CrossRefPubMed
9.
Zurück zum Zitat Packer RJ, Gutmann DH, Rubenstein A, Viskochil D, Zimmerman RA, Vezina G, Small J, Korf B: Plexiform neurofibromas in NF1: toward biologic-based therapy. Neurology. 2002, 58: 1461-1470.CrossRefPubMed Packer RJ, Gutmann DH, Rubenstein A, Viskochil D, Zimmerman RA, Vezina G, Small J, Korf B: Plexiform neurofibromas in NF1: toward biologic-based therapy. Neurology. 2002, 58: 1461-1470.CrossRefPubMed
10.
Zurück zum Zitat Friedrich RE, Korf B, Funsterer C, Mautner VF: Growth type of plexiform neurofibromas in NF1 determined on magnetic resonance images. Anticancer Res. 2003, 23: 949-952.PubMed Friedrich RE, Korf B, Funsterer C, Mautner VF: Growth type of plexiform neurofibromas in NF1 determined on magnetic resonance images. Anticancer Res. 2003, 23: 949-952.PubMed
11.
Zurück zum Zitat Friedrich RE, Schmelzle R, Hartmann M, Mautner VF: Subtotal and total resection of superficial plexiform neurofibromas of face and neck. J Craniomaxillofac Surg. 2005, Friedrich RE, Schmelzle R, Hartmann M, Mautner VF: Subtotal and total resection of superficial plexiform neurofibromas of face and neck. J Craniomaxillofac Surg. 2005,
Metadaten
Titel
Resection of small plexiform neurofibromas in neurofibromatosis type 1 children
verfasst von
Reinhard E Friedrich
Rainer Schmelzle
Melanie Hartmann
Carsten Fünsterer
Victor-F Mautner
Publikationsdatum
01.12.2005
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2005
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-3-6

Weitere Artikel der Ausgabe 1/2005

World Journal of Surgical Oncology 1/2005 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.